Axon CRO granted 15,810 performance stock units

AXON ENTERPRISE, INC. reported that Chief Revenue Officer Cameron Brooks acquired 15,810 shares of common stock through the certification of performance-based restricted stock units (XSUs) under the 2024 eXponential Stock Plan.

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. reported that Chief Revenue Officer Cameron Brooks acquired 15,810 shares of common stock through the certification of performance-based restricted stock units (XSUs) under the 2024 eXponential Stock Plan. These units relate to the fourth tranche, whose performance conditions were certified as met on August 16, 2026. The tranche is scheduled to vest on April 1, 2027, subject to continued employment, and the resulting shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding any shares withheld or sold for taxes. Following this award, Brooks holds 67,980.933 shares of Axon common stock directly.

Insider Trade Summary

Grant/Award: 15,810 shares

Grant/Award 1 txn

Insider Brooks Cameron

Role CHIEF REVENUE OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	15,810	$0.00	$0.00

Holdings After Transaction: Common Stock — 67,980.933 shares (Direct)

Footnotes (1)

1. F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Key Figures

Shares acquired: 15,810 shares Price per share: $0.0000 per share Shares held after transaction: 67,980.933 shares +3 more

6 metrics

Shares acquired 15,810 shares Performance-based restricted stock units (fourth tranche of XSUs) credited August 16, 2026

Price per share $0.0000 per share Reported value for the XSU-related common stock acquisition

Shares held after transaction 67,980.933 shares Direct ownership of Axon common stock following the award

Tranche performance certification date August 16, 2026 Date Compensation Committee certified performance conditions as met for the fourth XSU tranche

Vesting date April 1, 2027 Scheduled vesting date for the fourth XSU tranche, subject to continued employment

Minimum holding period end December 31, 2030 Latest date through which vested tranche shares must be held, absent earlier subsequent-tranche vesting

Key Terms

performance-based restricted stock units, eXponential Stock Plan, Compensation Committee, minimum holding period

4 terms

performance-based restricted stock units financial

"The transaction consists of performance-based restricted stock units (collectively, "XSUs")"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

eXponential Stock Plan financial

"granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"

Compensation Committee financial

"were certified by the issuer's Compensation Committee of the Board of Directors"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

minimum holding period financial

"shares deliverable for the Tranche are subject to a minimum holding period"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did AXON (AXON) grant to Chief Revenue Officer Cameron Brooks?

AXON granted Cameron Brooks 15,810 performance-based restricted stock units (XSUs) tied to a fourth tranche under the 2024 eXponential Stock Plan. The performance conditions for this tranche were certified as met on August 16, 2026 by the Compensation Committee.

When do Cameron Brooks’ new AXON (AXON) XSUs vest?

The reported XSUs for Cameron Brooks are scheduled to vest on April 1, 2027, subject to his continued employment through that date. Only after vesting will shares be deliverable, and they will then be subject to a minimum holding period.

What is the holding period for Cameron Brooks’ AXON (AXON) tranche shares?

Shares from the vested tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the date a subsequent XSUs tranche vests. This holding requirement excludes any shares withheld or sold to cover applicable taxes.

How many AXON (AXON) shares does Cameron Brooks hold after this transaction?

After this award, Cameron Brooks directly holds 67,980.933 shares of AXON common stock. This total reflects his ownership following the certification-related acquisition of 15,810 XSUs for the fourth tranche under the 2024 eXponential Stock Plan.

Was cash paid per share for Cameron Brooks’ AXON (AXON) stock acquisition?

No cash price was paid per share; the transaction is reported at $0.0000 per share. The acquisition represents a grant/award of performance-based restricted stock units rather than an open-market purchase of AXON common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 05:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brooks Cameron

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF REVENUE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/16/2026		A(1)		15,810	A	$0	67,980.933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Remarks:

	/s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)